SCHEMBL5280682

SCHEMBL5280682

FC(F)(F)c1ccccc1CNCCCNc1nsc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 1/20 0.45
EPHX2 P34913 1/20 0.43
EPAS1 Q99814 4/20 0.38
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37
AURKB Q96GD4 1/20 0.37
EGFR P00533 1/20 0.36
CYP3A4 P08684 1/20 0.36
CD38 P28907 1/20 0.36
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13202688 0.81 EPHX2 (0.45) EPHX2EPAS1ACHEKDM4E
SCHEMBL13202796 0.79 EPAS1 (0.56) EPHX2EPAS1ACHEKDM4EHSD17B10
SCHEMBL2977361 0.76 HTR7 (0.43) EPHX2
SCHEMBL2972570 0.76 MPO (0.41) SCN8AEPHX2AURKARPS6KB1AURKB
SCHEMBL13202707 0.75 CHRM2 (0.54) SCN8AEPAS1KDM4ETSHR
SCHEMBL13202694 0.75 EPAS1 (0.52) EPAS1ACHE
SCHEMBL2977429 0.74 EPAS1 (0.44) EPAS1CYP3A4KDM4ECA12CA2
SCHEMBL13202724 0.74 SCN8A (0.44) SCN8AEPHX2EPAS1
SCHEMBL13202710 0.74 EPAS1 (0.49) SCN8AEPAS1
SCHEMBL13202776 0.73 EPAS1 (0.59) EPHX2EPAS1ACHEKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776847-B2 Benzisothiazoles useful for treating or preventing HCV infection RIGEL PHARMACEUTICALS, INC. (US) 2010-08-17 US disclosed
US-7776847-B2 Benzisothiazoles useful for treating or preventing HCV infection RIGEL PHARMACEUTICALS, INC. (US) 2010-08-17 US disclosed
EP-1853573-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION Rigel Pharmaceuticals, Inc. (US) 2007-11-14 EP disclosed
WO-2006091858-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION RIGEL PHARMACEUTICALS, INC. (US) 2006-08-31 WO disclosed